Protein tyrosine kinases, p56lck and p59fyn, and MAP kinase JNK1 provide and early signal required for upregulation of Fas ligand expression in aburatubolactam C-induced apoptosis of human Jurkat T cells

Journal of Microbiology and Biotechnology

Volumn 15, Issue 4, 2005, Pages 756-766

  Bae, Myung Ae ^a,d   Jun, Do Youn ^a   Kim, Kyung Min ^a   Kim, Sang Kook ^a   Chun, Jang Soo ^b   Taub, Dennis ^c   Park, Wan ^a   Moon, Byung Jo ^a   Kim, Young Ho ^a  

^a Kyungpook National University   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Aburatubolactam C; Apoptosis; FasL upregulation; PKC ERK signaling pathway; PTK activator; PTK JNK signaling pathway

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ABURATUBOLACTAM C; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; GENISTEIN; LACTAM DERIVATIVE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN KINASE C; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LEUKEMIA CELL LINE; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

EID: 24644505795     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ashe, P. C. and M. D. Berry. 2003. Apoptotic signaling cascades. Prog. Neuropsychopharmacol. Biol. Psychiatry 27: 199-214.
2. fyn. J. Biol. Chem. 271: 5968-5971.
3. Bae, M. A., H. S. Kang, S. W. Rue, J. H. Seu, and Y. H. Kim. 1998. Enhanced expression of Fas ligand is associated with aburatubolactam C-induced apoptosis in human Jurkat T cells. Biochem. Biophys. Res. Commun. 246: 276-281.
4. Bae, M. A., K. Yamada, Y. Ijuin, T. Tsuji, and K. Yazawa. 1996. Aburatubolactam A, a novel inhibitor of superoxide anion generation from a marine microorganism. Heterocyclic Commun. 2: 315-318.
5. Bae, M. A., K. Yamada, D. Uemura, J. H. Seu, and Y. H. Kim. 1998. Aburatubolatam C, a novel apoptosis-inducing substance produced by marine Streptomyces sp. SCRC A-20. J. Microbiol. Biotech. 8: 455-460.
6. Cascino, I., G. Papoff., R. De Maria, R. Testi, and G. Ruberti. 1996. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protect tumor cells from Fas-mediated apoptosis. J. Immunol. 156: 13-17.
7. Chang, S. H., C. D. Oh, M. S. Yang, S. S. Kang, Y. S. Lee, J. K. Sonn, and J. S. Chun. 1998. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J. Biol. Chem. 273: 19213-19219.
8. Datta, R., Y. Manome, N. Taneja, L. H. Boise, R. Weichselbaum, C. B. Thompson, C. A. Slapak, and D. Kufe. 1995. Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ. 6: 363-370.
9. Eichhorst, S. T., M. Muller, M. Li-Weber, H. Schulze-Bergkamen, P. Angel, and P. H. Krammer. 2000. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol. Cell. Biol. 20: 7826-7837.
10. Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, E. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. ZAP tyrosine kinase is required for the up-regulation of FAS ligand in activation-induced T cell apoptosis. J. Immunol. 159: 1135-1139.
11. Faris, M., N. Kokot, K. Latinis, S. Kasibhatla, D. R. Green, G. A. Koretzky, and A. Nel. 1998. The c-jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by upregulating Fas ligand expression. J. Immunol. 160: 134-144.
12. Friesen, C., I. Herr, P. H. Krammer, and K. M. Debatin. 1996. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2: 574-578.
13. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
14. Hannun, Y. A. 1997. Apoptosis and dilemma of cancer chemotheraphy. Blood 89: 1845-1853.
15. Herr, I. and K. M. Debatin. 2001. Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614.
16. Hyer, M. L., C. Voelkel-Johnson, S. Rubinchik, J. Dong, and J. S. Norris. 2000. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis. Mol. Ther. 2: 348-358.
17. ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 178: 1199-1208.
18. Park, H. W., D. Y. Jun, and Y. H. Kim. 2002. Apoptotic activity of insect pathogenic fungus Paecilomyces japonica toward human acute leukemia Jurkat T cells is associated with mitochondria-dependent caspase-3 activation regulated by bcl-2. J. Microbiol. Biotechnol. 12: 950-956.
19. Jarvis, W D., K. L. Auer, M. Spector, G. Kunos, S. Grant, P. Hylemon, R. Mikkelsen, and P. Dent. 1997. Positive and negative regulation of JNK1 by protein kinase C and p42 MAP kinase in adult rat hepatocytes. FEBS Lett. 412: 9-14.
20. lck kinase activity and the tyrosine phosphorylation of a 97-kDa protein. Proc. Natl. Acad. Sci. USA 90: 3187-3191.
21. Krueger, A., S. C. Fas, S. Baumann, and P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193: 58-69.
22. Lamy, T., J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr. 1998. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 92: 4771-4777.
23. Liu, B. and Z. Fan. 2001. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway. Oncogene 20: 3726-3734.
24. Muller, M., S. Strand, H. Hug, E. M. Heinemann, H. Walczak, W. J. Hofmann, W. Stremmel, P. H. Krammer, and P. R. Galle. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413.
25. Nagarkatti, N. and B. A. Davis. 2003. Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand. Cancer Chemother Phamarcol. 51: 284-290.
26. lck in T-cell receptor/CD3 mediated apoptosis and Fas-ligand induction in Jurkat T cells. Biochem. Biophys. Res. Commun. 213: 994-1001.
27. Pahlavani, M. A. 1998. T cell signaling: Effect of age. Front. Biosc. 3: 1120-1133.
28. Ramoneda, B. M. and R. Perez-Tomas. 2002. Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosin. Biochem. Pharmacol. 63: 463-469.
29. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687.
30. Shen, L., A. C. T. Liang, L. Lu, W. Y. Au, Y. L. Kwong, R. H. S. Liang, and G. Srivastava. 2002. Frequent deletion of Fas gene sequence encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma. Am. J. Pathol. 161: 2123-2131.
31. Shimizu, S., Y. Eguchi, H. Kosaka, W. Kamiike, H. Matsuda, and Y. Tsujimoto. 1995. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374: 811-813.
32. Simonian, P. L., D. A. Grillot, and G. Nunez. 1997. Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death. Blood 90: 1208-1216.
33. Stadheim, T. A. and G. L. Kusera. 1998. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis. Biochem. Biophys. Res. Commun. 245: 266-271.
34. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
35. Tsutsumi, A. T., M. Kubo, H. Fujii, J. Freire-Moar, C. W. Turck, and J. T. Ransom. 1993. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells. J. Immunol. 150: 1746-1754.
36. Tudor, G., A. Aguilera, D. O. Halverson, N. D. Laing, and E. A. Sausville. 2000. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ. 7: 574-586.
37. lck) during T-cell activation. Mol. Cell. Biol. 8: 4353-4361.
38. Villalba, M., S. Kasibhatla, L. Genestier, A. Mahboubi, D. R. Green, and A. Altman. 1999. Protein kinase C theta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J. Immunol. 163: 5813-5819.
39. Widmann, C., S. Gibson, M. B. Jarpe, and G. Johnson. 1999. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 79: 143-180.
40. Wilson, D. J., K. A. Fortner, D. H. Lynch, R. R. Mattingly, I. G. Macara, J. A. Posada, and R. C. Budd. 1996. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26: 989-994.
41. Zhu, L., X. Yu, Y. Akatsuka, J. A. Cooper, and C. Anasetti. 1999. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 97: 26-35.
42. Zhuang, S., M. C. Lynch, and I. E. Kochevar. 1998. Activation of protein kinase C is required for protection of cells against apoptosis induced by singlet oxygen. FEBS Lett. 437: 158-162.